These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 28112079)

  • 1. Reply to: Letter to the Editor: Sodium nitroprusside for schizophrenia: could methodological variables account for the different results obtained?
    Stone J; Koychev I; Reilly T; McGuire P
    Psychol Med; 2017 Apr; 47(5):983. PubMed ID: 28112079
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter to the Editor: Sodium nitroprusside for schizophrenia: could methodological variables account for the different results obtained?
    Maia-de-Oliveira JP; Baker GB; Dursun SM; Hallak JE
    Psychol Med; 2017 Apr; 47(5):981-982. PubMed ID: 27931266
    [No Abstract]   [Full Text] [Related]  

  • 3. The role of striatum and prefrontal cortex in the prevention of amphetamine-induced schizophrenia-like effects mediated by nitric oxide compounds.
    Issy AC; Dos-Santos-Pereira M; Pedrazzi JFC; Kubrusly RCC; Del-Bel E
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Aug; 86():353-362. PubMed ID: 29555252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid improvement of acute schizophrenia symptoms after intravenous sodium nitroprusside: a randomized, double-blind, placebo-controlled trial.
    Hallak JE; Maia-de-Oliveira JP; Abrao J; Evora PR; Zuardi AW; Crippa JA; Belmonte-de-Abreu P; Baker GB; Dursun SM
    JAMA Psychiatry; 2013 Jul; 70(7):668-76. PubMed ID: 23699763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of sodium nitroprusside in the acute dizocilpine (MK-801) animal model of schizophrenia.
    Wang X; Ding S; Lu Y; Jiao Z; Zhang L; Zhang Y; Yang Y; Zhang Y; Li W; Lv L
    Brain Res Bull; 2019 Apr; 147():140-147. PubMed ID: 30772438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Letter to the Editor: Comparing delusional disorder and schizophrenia: a comment on Hui et al. (2015)-–a reply.
    Hui CL; Lee EH; Chang WC; Chan SK; Chen EY
    Psychol Med; 2016 May; 46(7):1561-2. PubMed ID: 26691196
    [No Abstract]   [Full Text] [Related]  

  • 7. Letter to the Editor: Concepts and methods when considering negative symptom course: a reply.
    Savill M; Priebe S
    Psychol Med; 2015 Aug; 45(11):2459-60. PubMed ID: 25919939
    [No Abstract]   [Full Text] [Related]  

  • 8. Letter to the editor: reply to Legare et al.
    van Westrhenen R; Schulte PF; Sommer I
    Med Hypotheses; 2014 Sep; 83(3):418. PubMed ID: 25012779
    [No Abstract]   [Full Text] [Related]  

  • 9. Authors' Reply to the Letter to the Editor "Validity of an Alcohol Use Disorder Identification Test: Methodological Issues".
    Chang JW; Kim JS; Jung JG; Kim SS; Yoon SJ; Jang HS
    Korean J Fam Med; 2017 Mar; 38(2):108. PubMed ID: 28360989
    [No Abstract]   [Full Text] [Related]  

  • 10. The Nitric Oxide (NO) Donor Sodium Nitroprusside (SNP) and Its Potential for the Schizophrenia Therapy: Lights and Shadows.
    Zoupa E; Pitsikas N
    Molecules; 2021 May; 26(11):. PubMed ID: 34073534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabidiol and Sodium Nitroprusside: Two Novel Neuromodulatory Pharmacological Interventions to Treat and Prevent Psychosis.
    Crippa JA; Hallak JE; Abílio VC; de Lacerda AL; Zuardi AW
    CNS Neurol Disord Drug Targets; 2015; 14(8):970-8. PubMed ID: 26350340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reply to the Letter to the Editor by Murru et al.
    Santelmann H; Baethge C
    Bipolar Disord; 2016 Feb; 18(1):81-2. PubMed ID: 26842738
    [No Abstract]   [Full Text] [Related]  

  • 13. Reply to Letter to the Editor by Radner W, Maaijwee K, de Smet MD, Benesch T, Ettl A: Different Use of Radner Reading Charts and No Methodological Bias Influencing the Results.
    Kortuem C; Marx T; Altpeter EK; Trauzettel-Klosinski S; Kuester-Gruber S
    Ophthalmic Res; 2022; 65(2):237-238. PubMed ID: 34856555
    [No Abstract]   [Full Text] [Related]  

  • 14. Reply to "Letter to Editor regarding: 'Between human and AI: methodological issues on reliability, effectiveness and accuracy to avoid misinterpretation'".
    Bellini V; Semeraro F; Montomoli J; Cascella M; Bignami E
    Curr Med Res Opin; 2024 Sep; ():1. PubMed ID: 39308449
    [No Abstract]   [Full Text] [Related]  

  • 15. Reply to Letter to the Editor: "Critical Review: Methodological and Interpretative Issues in COVID-19 and Acute Coronary Syndrome Study".
    Özbek Ö; Can MM
    Anatol J Cardiol; 2024 Oct; 28(11):562-3. PubMed ID: 39417292
    [No Abstract]   [Full Text] [Related]  

  • 16. Letter to the editor: Critique of Bahorik et al. (2013)--'Underreporting of drug use among individuals with schizophrenia: prevalence and predictors'--a reply.
    Bahorik AL; Newhill CE; Queen CC; Eack SM
    Psychol Med; 2014 Feb; 44(3):670-1. PubMed ID: 24524169
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of sodium nitroprusside on psychotic symptoms and spatial working memory in patients with schizophrenia: a randomized, double-blind, placebo-controlled trial.
    Stone JM; Morrison PD; Koychev I; Gao F; Reilly TJ; Kolanko M; Mohammadinasab A; Kapur S; McGuire PK
    Psychol Med; 2016 Dec; 46(16):3443-3450. PubMed ID: 27655012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sodium nitroprusside is effective in preventing and/or reversing the development of schizophrenia-related behaviors in an animal model: The SHR strain.
    Diana MC; Peres FF; Justi V; Bressan RA; Lacerda ALT; Crippa JA; Hallak JEC; Abilio VC
    CNS Neurosci Ther; 2018 Jul; 24(7):624-632. PubMed ID: 29656549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reply letter to: Letter to the editor on the article "Endoscopic resection versus radical gastrectomy for early gastric cancer in Asia: A meta-analysis.
    Zhang CD; Ning FL; Dai DQ
    Int J Surg; 2018 Jun; 54(Pt A):301-302. PubMed ID: 29396222
    [No Abstract]   [Full Text] [Related]  

  • 20. Reply to Letter to the Editor - Leptin levels in Gaucher disease type I patients: A methodological approach.
    Doneda D; Lopes AL; Teixeira BC; Mittelstadt SD; Moulin CC; Schwartz IV
    Clin Nutr; 2015 Apr; 34(2):329. PubMed ID: 25600498
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.